Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
Multi-input and Multi-variable systems01:22

Multi-input and Multi-variable systems

Cruise control systems in cars are designed as multi-input systems to maintain a driver's desired speed while compensating for external disturbances such as changes in terrain. The block diagram for a cruise control system typically includes two main inputs: the desired speed set by the driver and any external disturbances, such as the incline of the road. By adjusting the engine throttle, the system maintains the vehicle's speed as close to the desired value as possible.
In the absence of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative Analysis of Capillary HbA1c and CGM-Derived GMI Estimates: A Real-World Data from a Single Center.

Diabetes technology & therapeutics·2026
Same author

Early Assessment of Teplizumab Treatment Response Using Continuous Glucose Monitoring.

Diabetes technology & therapeutics·2026
Same author

Bariatric Surgery in Adolescents With Obesity: Weight and Cardiometabolic Outcomes-Real-World Data.

Obesity (Silver Spring, Md.)·2026
Same author

Adjunctive Treatment with GLP-1 and Dual GLP-1/GIP Receptor Agonists for People with Type 1 Diabetes: Consensus Report and Practical Guidelines for Safe Use.

Diabetes technology & therapeutics·2026
Same author

Extension of the Phase 3 Trial of Somatrogon in Children with Growth Hormone Deficiency: 3 Years of Safety and Efficacy.

Hormone research in paediatrics·2026
Same author

Postprandial glucose response to a low-sucrose chocolate spread in adults with type 1 diabetes: a randomized, double-blinded, cross-over, controlled trial.

Nutrition & diabetes·2026
Same journal

Continuous Glucose Monitoring Metrics and Perinatal Outcomes in Pregnant Women with Type 2 Diabetes.

Diabetes technology & therapeutics·2026
Same journal

Invited Commentary: Using Large Clinical Databases.

Diabetes technology & therapeutics·2026
Same journal

Impact of Technology Introduction on Glycemic Control of People Living with Type 1 Diabetes in Belgium: An Observational, Real-World Study.

Diabetes technology & therapeutics·2026
Same journal

Differences in Achieving Stringent Glycemic Targets Among Youth with Type 1 Diabetes: A SWEET Registry Study.

Diabetes technology & therapeutics·2026
Same journal

<i>Letter:</i> "Nocturnal Hypoglycemia: Characterization with Continuous Glucose Monitoring in a Real-World Setting".

Diabetes technology & therapeutics·2026
Same journal

Transient Benign Ketosis Is Common in Type 1 Diabetes During Very-Low Carbohydrate States: Novel Data from Continuous Ketone Sensor.

Diabetes technology & therapeutics·2026
See all related articles

Related Experiment Video

Updated: May 30, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Automatic learning algorithm for the MD-logic artificial pancreas system.

Shahar Miller1, Revital Nimri, Eran Atlas

  • 1The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, The National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.

Diabetes Technology & Therapeutics
|July 22, 2011
PubMed
Summary
This summary is machine-generated.

A new real-time learning algorithm for artificial pancreas systems improves glucose control in children and adolescents. The algorithm effectively adjusts insulin treatment, reducing hypoglycemia and enhancing time in range for diabetes management.

Related Experiment Videos

Last Updated: May 30, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Area of Science:

  • Biomedical Engineering
  • Artificial Intelligence in Medicine
  • Endocrinology

Background:

  • Artificial pancreas systems aim to improve glucose control in diabetes.
  • Real-time learning algorithms can enhance the adaptability of artificial pancreas systems.
  • The MD-Logic Artificial Pancreas (MDLAP) system integrates novel learning algorithms.

Purpose of the Study:

  • To describe a novel learning algorithm for artificial pancreas systems.
  • To evaluate the performance of this algorithm integrated into the MDLAP system.
  • To assess the algorithm's effectiveness in glucose-insulin dynamics management.

Main Methods:

  • Developed a two-component learning algorithm: Initial Learning Algorithm and Runtime Learning Algorithm.
  • Integrated the algorithm into the MDLAP system for testing.
  • Conducted simulations using the UVA/Padova simulator across various age groups and insulin sensitivity conditions.

Main Results:

  • Significantly improved time glucose levels were within 70-180 mg/dL for children/adolescents (P<0.0001).
  • Significantly reduced time glucose levels were below 70 mg/dL by sevenfold under varying insulin sensitivity (P<0.001).
  • Correlated with a significant reduction in the Low Blood Glucose Index (P<0.001).

Conclusions:

  • The novel algorithm effectively characterizes patient profiles from open-loop data.
  • The algorithm enhances glycemic control during closed-loop operation in varying conditions.
  • Findings support the need for corroboratory clinical trials for this artificial pancreas learning algorithm.